These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome. Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586 [TBL] [Abstract][Full Text] [Related]
4. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke. Rocco A; Sykora M; Ringleb P; Diedler J Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177 [TBL] [Abstract][Full Text] [Related]
5. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke. Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726 [TBL] [Abstract][Full Text] [Related]
7. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. Cappellari M; Deluca C; Tinazzi M; Tomelleri G; Carletti M; Fiaschi A; Bovi P; Moretto G J Neurol Sci; 2011 Sep; 308(1-2):128-34. PubMed ID: 21683374 [TBL] [Abstract][Full Text] [Related]
8. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317 [TBL] [Abstract][Full Text] [Related]
9. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Scheitz JF; Seiffge DJ; Tütüncü S; Gensicke H; Audebert HJ; Bonati LH; Fiebach JB; Tränka C; Lyrer PA; Endres M; Engelter ST; Nolte CH Stroke; 2014 Feb; 45(2):509-14. PubMed ID: 24368561 [TBL] [Abstract][Full Text] [Related]
10. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755 [TBL] [Abstract][Full Text] [Related]
11. Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis. Mowla A; Shah H; Lail NS; Vaughn CB; Shirani P; Sawyer RN Cerebrovasc Dis; 2020; 49(5):503-508. PubMed ID: 32927457 [TBL] [Abstract][Full Text] [Related]
12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405 [TBL] [Abstract][Full Text] [Related]
13. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients. Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y; Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494 [TBL] [Abstract][Full Text] [Related]
14. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466 [TBL] [Abstract][Full Text] [Related]
15. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis. Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215 [TBL] [Abstract][Full Text] [Related]
16. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Ahmed N; Dávalos A; Eriksson N; Ford GA; Glahn J; Hennerici M; Mikulik R; Kaste M; Lees KR; Lindsberg PJ; Toni D; Arch Neurol; 2010 Sep; 67(9):1123-30. PubMed ID: 20837858 [TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis. Malhotra K; Katsanos AH; Goyal N; Tayal A; Gensicke H; Mitsias PD; De Marchis GM; Berge E; Alexandrov AW; Alexandrov AV; Tsivgoulis G Neurology; 2020 Jul; 95(2):e121-e130. PubMed ID: 32554767 [TBL] [Abstract][Full Text] [Related]
18. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis. Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038 [TBL] [Abstract][Full Text] [Related]
19. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study. Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]